Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti prostate cancer therapy: Aptamer-functionalized, curcumin and cabazitaxel co-delivered, tumor targeted lipid-polymer hybrid nanoparticles
Yougan Chen, Yuanyuan Deng, Chenyao Zhu, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 127, pp. 110181-110181
Open Access | Times Cited: 102

Showing 1-25 of 102 citing articles:

Aptamer-Functionalized Nanoparticles in Targeted Delivery and Cancer Therapy
Zhaoying Fu, Jim Xiang
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 23, pp. 9123-9123
Open Access | Times Cited: 151
Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response
Milad Ashrafizadeh, Mahshid Deldar Abad Paskeh, Sepideh Mirzaei, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 111
Lipid polymer hybrid nanoparticles: a custom-tailored next-generation approach for cancer therapeutics
Kavita R. Gajbhiye, Rajesh Salve, Mahavir Narwade, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 80
Novel Tumor-Targeting Nanoparticles for Cancer Treatment—A Review
Adelina-Gabriela Niculescu, Alexandru Mihai Grumezescu
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 5253-5253
Open Access | Times Cited: 73
Nano formulation approaches for curcumin delivery- a review
Gayathri Kumararaja, Mahendran Bhaskaran, Chelliah Selvam, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 82, pp. 104326-104326
Closed Access | Times Cited: 62
Advances in aptamer-mediated targeted delivery system for cancer treatment
Shiming He, Yue Du, Hongyu Tao, et al.
International Journal of Biological Macromolecules (2023) Vol. 238, pp. 124173-124173
Closed Access | Times Cited: 58
Multifunctional nanoparticle for cancer therapy
Yan Gao, Kaiyu Wang, Jin Zhang, et al.
MedComm (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 45
Combined chemotherapy with cyclooxygenase-2 (COX-2) inhibitors in treating human cancers: Recent advancement
Shuangshuang Li, Min Jiang, Lu Wang, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 129, pp. 110389-110389
Open Access | Times Cited: 120
Lipid polymer hybrid nanocarriers: Insights into synthesis aspects, characterization, release mechanisms, surface functionalization and potential implications
Saurabh Shah, Paras Famta, Rajeev Singh Raghuvanshi, et al.
Colloids and Interface Science Communications (2021) Vol. 46, pp. 100570-100570
Open Access | Times Cited: 78
Current Perspectives on Taxanes: Focus on Their Bioactivity, Delivery and Combination Therapy
Jan Škubník, Vladimíra Svobodová Pavlíčková, Tomáš Ruml, et al.
Plants (2021) Vol. 10, Iss. 3, pp. 569-569
Open Access | Times Cited: 73
Nanotechnological Approaches in Prostate Cancer Therapy: Integration of engineering and biology
Milad Ashrafizadeh, Shahin Aghamiri, Shing Cheng Tan, et al.
Nano Today (2022) Vol. 45, pp. 101532-101532
Open Access | Times Cited: 60
Nanoscale bioconjugates: A review of the structural attributes of drug-loaded nanocarrier conjugates for selective cancer therapy
Wenjie Zhang, Reza Taheri‐Ledari, Fatemeh Ganjali, et al.
Heliyon (2022) Vol. 8, Iss. 6, pp. e09577-e09577
Open Access | Times Cited: 54
Curcumin delivery and co-delivery based on nanomaterials as an effective approach for cancer therapy
Mehrab Pourmadadi, Parisa Abbasi, Mohammad Mahdi Eshaghi, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 78, pp. 103982-103982
Closed Access | Times Cited: 45
Recent Progress in Nanotechnology Improving the Therapeutic Potential of Polyphenols for Cancer
Ítalo Rennan Sousa Vieira, Letícia Tessaro, Alan Kelbis Oliveira Lima, et al.
Nutrients (2023) Vol. 15, Iss. 14, pp. 3136-3136
Open Access | Times Cited: 41
Advanced cancer targeting using aptamer functionalized nanocarriers for site-specific cargo delivery
Mahavir Narwade, Aazam Shaikh, Kavita R. Gajbhiye, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 40
Recent advances and future perspectives in the therapeutics of prostate cancer
Ganji Lakshmi Varaprasad, Vivek Gupta, K. Satya Prasad, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 27
Lipid–Polymer Hybrid Nanosystems: A Rational Fusion for Advanced Therapeutic Delivery
Shweta Jain, Mudit Kumar, Pushpendra Kumar, et al.
Journal of Functional Biomaterials (2023) Vol. 14, Iss. 9, pp. 437-437
Open Access | Times Cited: 25
Prospects of Curcumin Nanoformulations in Cancer Management
Hilda Amekyeh, Enas Alkhader, Rayan Sabra, et al.
Molecules (2022) Vol. 27, Iss. 2, pp. 361-361
Open Access | Times Cited: 36
Curcumin in the treatment of urological cancers: Therapeutic targets, challenges and prospects
Mehrdad Hashemi, Sepideh Mirzaei, Maryamsadat Barati, et al.
Life Sciences (2022) Vol. 309, pp. 120984-120984
Closed Access | Times Cited: 29
Emerging Trends of Nanomedicines in the Management of Prostate Cancer: Perspectives and Potential Applications
Rohitas Deshmukh, Vaibhav Singh, Ranjit K. Harwansh, et al.
Pharmaceutics (2024) Vol. 16, Iss. 3, pp. 297-297
Open Access | Times Cited: 8
PLGA nanomedical consignation: A novel approach for the management of prostate cancer
Tenzin Sonam Dongsar, Tenzin Tsering Dongsar, Garima Gupta, et al.
International Journal of Pharmaceutics (2024) Vol. 652, pp. 123808-123808
Closed Access | Times Cited: 7
Revolutionizing biomedicine: Aptamer-based nanomaterials and nanodevices for therapeutic applications
Rajkumari Urmi, Pallabi Banerjee, Manisha Singh, et al.
Biotechnology Reports (2024) Vol. 42, pp. e00843-e00843
Open Access | Times Cited: 7
Combination prostate cancer therapy: Prostate-specific membranes antigen targeted, pH-sensitive nanoparticles loaded with doxorubicin and tanshinone
Guanxing Sun, Kai Sun, Jie Sun
Drug Delivery (2021) Vol. 28, Iss. 1, pp. 1132-1140
Open Access | Times Cited: 39
Lung cancer chemotherapy using nanoparticles: Enhanced target ability of redox-responsive and pH-sensitive cisplatin prodrug and paclitaxel
Baohua Wang, Wenxia Hu, Hongjiang Yan, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 136, pp. 111249-111249
Open Access | Times Cited: 38
Recent advances in lipid-engineered multifunctional nanophytomedicines for cancer targeting
Mayank Handa, Sarwar Beg, Rahul Shukla, et al.
Journal of Controlled Release (2021) Vol. 340, pp. 48-59
Open Access | Times Cited: 37
Page 1 - Next Page

Scroll to top